EXOZ eXoZymes, Inc.
Healthcare$9.91-0.10%ClosedMarket Cap: $84.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
54.91
P/S
0.00
EV/EBITDA
-8.50
DCF Value
$0.14
FCF Yield
-8.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-220.6%
ROA
-240.7%
ROIC
-362.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.4M | $-2.4M | $— | — |
| Q4 null | $0.00 | Infinity% | $-2.7M | $-2.7M | $— | — |
| FY null | $0.00 | NaN% | $-9.7M | $-9.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.5M | $-2.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.5M | $-2.4M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.0M | $-1.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-2.0M | $-1.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-5.9M | $-5.9M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.6M | $-1.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.3M | $-1.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.0M | $-1.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-985.0K | $-1.1M | $-0.14 | — |